WASHINGTON, Aug 12 (Reuters) - CombiMatrix Corp (CBMX.O), a biotechnology company, may periodically sell up to $100 million in common stock, according to a filing made on Tuesday with the U.S. Securities and Exchange Commission.
Under a shelf registration, a company may sell securities in one or more separate offerings with the size, price and terms to be determined at the time of sale.
(Reporting by John Poirier)
WASHINGTON (Reuters) - Sales of previously owned U.S. homes jumped last month to their highest level in nearly three years, the latest sign that the economic recovery was gaining steam, after growing below expectations in the third quarter.
Democrats are on the verge of passing landmark legislation by Christmas, with only one more hurdle remaining. Full Article | Video
Borrowing the dollar cheaply to fund purchases of higher-yielding assets was a no-brainer in 2009, but will it be a safe bet in 2010? Full Article
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
